Agreement Between Oral and Cervical Human Papillomavirus Infection in a French Cohort

NACompletedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

May 11, 2016

Primary Completion Date

December 31, 2020

Study Completion Date

April 30, 2022

Conditions
Human Papillomavirus-Related Cervical Carcinoma
Interventions
OTHER

Agreement between oral and cervical HPV infection

"A total of 165 women will have a Pap test and an oral brushing performed on the day of inclusion. Risk factors for oral HPV infection will be defined using a self-administered survey summarizing the demographics and sexual behaviors.~A second oral brushing up to 18 months will be performed during a standard follow-up visit."

Trial Locations (4)

54000

Maternité Régionale Universitaire de Nancy, Nancy

54500

Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy

Unknown

Hôpital Nord Franche-Comté, Belfort

CHRU Besançon, Besançon

All Listed Sponsors
lead

Institut de Cancérologie de Lorraine

OTHER

NCT02774538 - Agreement Between Oral and Cervical Human Papillomavirus Infection in a French Cohort | Biotech Hunter | Biotech Hunter